vs

Side-by-side financial comparison of CME Group (CME) and TELUS CORP (TU). Click either name above to swap in a different company.

TELUS CORP is the larger business by last-quarter revenue ($3.7B vs $1.9B, roughly 2.0× CME Group). CME Group runs the higher net margin — 0.1% vs -4.8%, a 4.9% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 2.2%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Telus Corporation is a Canadian publicly traded holding company and conglomerate, headquartered in Vancouver, British Columbia, which is the parent company of several subsidiaries: Telus Communications offers telephony, television, data and Internet services; Telus Mobility offers wireless services; Telus Health operates companies that provide health products and services; and Telus Digital operates worldwide, providing multilingual customer service outsourcing and digital IT services. Telus ...

CME vs TU — Head-to-Head

Bigger by revenue
TU
TU
2.0× larger
TU
$3.7B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+12.3% gap
CME
14.5%
2.2%
TU
Higher net margin
CME
CME
4.9% more per $
CME
0.1%
-4.8%
TU

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
CME
CME
TU
TU
Revenue
$1.9B
$3.7B
Net Profit
$1.2M
$-178.8M
Gross Margin
90.2%
Operating Margin
0.1%
3.4%
Net Margin
0.1%
-4.8%
Revenue YoY
14.5%
2.2%
Net Profit YoY
20.7%
-210.9%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
TU
TU
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
$3.7B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
$3.6B
Net Profit
CME
CME
TU
TU
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$1.0B
$-178.8M
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
$161.3M
Gross Margin
CME
CME
TU
TU
Q1 26
Q4 25
Q3 25
Q2 25
90.2%
Q1 25
Q4 24
Q3 24
Q2 24
87.9%
Operating Margin
CME
CME
TU
TU
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
3.4%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
13.7%
Net Margin
CME
CME
TU
TU
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
60.6%
-4.8%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
4.4%
EPS (diluted)
CME
CME
TU
TU
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
TU
TU
Cash + ST InvestmentsLiquidity on hand
$2.4B
$2.7B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$11.8B
Total Assets
$202.0B
$44.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
TU
TU
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
$2.7B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
$676.7M
Total Debt
CME
CME
TU
TU
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
TU
TU
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$27.7B
$11.8B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
$12.4B
Total Assets
CME
CME
TU
TU
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$179.9B
$44.3B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B
$41.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
TU
TU
Operating Cash FlowLast quarter
$851.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
TU
TU
Q1 26
Q4 25
$1.1B
Q3 25
$968.1M
Q2 25
$1.1B
$851.2M
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$776.9M
$1.0B
Free Cash Flow
CME
CME
TU
TU
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
CME
CME
TU
TU
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
CME
CME
TU
TU
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
CME
CME
TU
TU
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×
6.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons